CORONA Remedies Announces 22nd AGM on July 9, 2026, via VC/OAVM
CORONA Remedies Limited will hold its 22nd Annual General Meeting on July 9, 2026, at 11:00 a.m. IST. The meeting will be conducted via Video Conferencing / Other Audio Visual Means (VC / OAVM).
This is a standard corporate announcement regarding an AGM, which is a routine event for listed companies. It does not involve any new business, financial results, or strategic changes that would significantly impact the company's operations or stock.
The announcement is a routine procedural update regarding the AGM and does not contain any financial or business performance information that would indicate a positive or negative sentiment.
CORONA Remedies Limited has announced that its 22nd Annual General Meeting (AGM) will be held on Thursday, July 09, 2026, at 11:00 a.m. (IST). The meeting will be conducted through Video Conferencing / Other Audio Visual Means (VC / OAVM) facility, in compliance with recent SEBI and Ministry of Corporate Affairs circulars. Copies of the newspaper advertisements intimating the AGM details, published on June 10, 2026, in Financial Express (English) and Financial Express (Gujarati) have been provided. The announcement also states that the information is available on the company's website at www.coronaremedies.com.
What to do with a filing like this
CORONA Remedies Limited filed this with the NSE as a statutory disclosure, categorised under agm. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by CORONA Remedies Limited. Read the original for the full detail.